The long-term goal of this project is to elucidate the cellular mechanisms of parathyroid hormone receptor (PTH1R) action. The PTH1R regulates extracellular calcium and phosphate homeostasis by its actions on kidney and bone. Like other G protein-coupled receptors, the PTH1R exhibits a cyclical process of activation, desensitization, internalization, and resensitization. Receptor desensitization provides a mechanism to protect cells against excessive stimulation, while resensitization guards cells against prolonged inactivity and hormone resistance. Unlike most other receptors, however, the PTH1R exhibits considerable cell- and tissue-specific differences in its activation. These differences cannot be ascribed to alternatively spliced receptor forms, receptor abundance, or G protein availability. Recent evidence suggests that the cytoplasmic adaptor protein ezrin-binding protein 50 kD (EBP50) may contribute to cell-specific PTH1R signaling and internalization. The central goal of the proposed studies is to examine the interaction and modulatory activity of EBP50 on all aspects of PTH1R cycling.
Four specific aims are developed to test the unifying hypothesis that EBP50 regulates ligand-specific responses of the PTH1R.
Aim 1 will characterize the effects of EBP50 on cell-specific PTH1R activation.
Aim 2 will describe EBP50 effects on PTH1R desensitization.
Aim 3 will identify structural determinants of EBP50 that are involved in PTH1R internalization.
Aim 4 will determine the effects of EBP50 on PTH1R recycling. The planned studies employ an array of cell biological, biochemical, and molecular biological techniques that will be applied to specific kidney and bone cells that are the primary targets of PTH action. Preliminary data provide provisional support and establish the feasibility for much of the proposed work. The planned studies will yield novel and important information on the mechanism and role by which the PTH1R regulates extracellular calcium homeostasis. The results will provide greater understanding of the initiation and termination of PTH1R action. The outcomes may suggest additional pathophysiological mechanisms causing PTH resistance and lead to new treatment opportunities.
|Treat, Anny Caceres; Wheeler, David S; Stolz, Donna B et al. (2016) The PDZ Protein Na+/H+ Exchanger Regulatory Factor-1 (NHERF1) Regulates Planar Cell Polarity and Motile Cilia Organization. PLoS One 11:e0153144|
|Sneddon, W Bruce; Ruiz, Giovanni W; Gallo, Luciana I et al. (2016) Convergent Signaling Pathways Regulate Parathyroid Hormone and Fibroblast Growth Factor-23 Action on NPT2A-mediated Phosphate Transport. J Biol Chem 291:18632-42|
|McGarvey, Jennifer C; Xiao, Kunhong; Bowman, Shanna L et al. (2016) Actin-Sorting Nexin 27 (SNX27)-Retromer Complex Mediates Rapid Parathyroid Hormone Receptor Recycling. J Biol Chem 291:10986-1002|
|Mamonova, Tatyana; Zhang, Qiangmin; Khajeh, Jahan Ali et al. (2015) Canonical and Noncanonical Sites Determine NPT2A Binding Selectivity to NHERF1 PDZ1. PLoS One 10:e0129554|
|Song, Gyun Jee; Leslie, Kristen L; Barrick, Stacey et al. (2015) Phosphorylation of ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) by Akt promotes stability and mitogenic function of S-phase kinase-associated protein-2 (Skp2). J Biol Chem 290:2879-87|
|Walsh, Dustin R; Nolin, Thomas D; Friedman, Peter A (2015) Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 Proteins. Pharmacol Rev 67:656-80|
|Loughran, Patricia A; Stolz, Donna B; Barrick, Stacey R et al. (2013) PEX7 and EBP50 target iNOS to the peroxisome in hepatocytes. Nitric Oxide 31:9-19|
|Wang, Bin; Yang, Yanmei; Liu, Li et al. (2013) NHERF1 regulation of PTH-dependent bimodal Pi transport in osteoblasts. Bone 52:268-77|
|Alonso, Veronica; Friedman, Peter A (2013) Minireview: ubiquitination-regulated G protein-coupled receptor signaling and trafficking. Mol Endocrinol 27:558-72|
|Song, Gyun Jee; Barrick, Stacey; Leslie, Kristen L et al. (2012) The scaffolding protein EBP50 promotes vascular smooth muscle cell proliferation and neointima formation by regulating Skp2 and p21(cip1). Arterioscler Thromb Vasc Biol 32:33-41|
Showing the most recent 10 out of 29 publications